KIORA PHARMACEUTICALS, INC. (KPRX) Total liabilities 2016–2025
KIORA PHARMACEUTICALS, INC. (KPRX) total liabilities at each fiscal year-end, per SEC filings.
$8.1MFY2025 · since FY2016: $10.1M → $8.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $8.1M | -24.2% |
| FY2024 | $10.7M | +41.1% |
| FY2023 | $7.6M | — |
| FY2021 | $5.6M | -0.4% |
| FY2020 | $5.6M | +59.7% |
| FY2019 | $3.5M | -34.7% |
| FY2018 | $5.3M | -67.1% |
| FY2017 | $16.2M | +61.4% |
| FY2016 | $10.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice